Prospective validation of the role of PET/CT in detecting disease after neoadjuvant chemotherapy in advanced ovarian cancer.
Elaine Yuen Phin LeePhilip Pun Ching IpKa Yu TseKeith Wan Hang ChiuMandy Man Yee ChuYu Ka ChaiPhilip Yuguang WuJessica Yun Pui LawShuk Tak KwokWan Kam ChiuHextan Yuen Sheung NganPublished in: European radiology (2024)
F]FDG PET/CT has comparable diagnostic accuracy compared to contrast-enhanced CT. • Contrast-enhanced CT will be suffice for surgical planning after neoadjuvant chemotherapy.
Keyphrases
- contrast enhanced
- neoadjuvant chemotherapy
- pet ct
- diffusion weighted
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- locally advanced
- lymph node
- positron emission tomography
- sentinel lymph node
- diffusion weighted imaging
- dual energy
- squamous cell carcinoma
- radiation therapy
- image quality
- early stage